Verrica Pharmaceuticals Inc (NASDAQ:VRCA)

6.73
Delayed Data
As of 3:59pm ET
 -0.29 / -4.13%
Today’s Change
1.77
Today|||52-Week Range
9.22
+144.73%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$295.9M

Company Description

Verrica Pharmaceuticals, Inc. is a dermatology therapeutics company, which engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its products include Pipeline VP-102, Pipeline VP-103, and Pipeline VP-315. The company was founded by Matthew Davidson on July 3, 2013 and is headquartered in West Chester, PA.

Contact Information

Verrica Pharmaceuticals, Inc.
44 West Gay Street
West Chester Pennsylvania 19380
P:(434) 453-3300
Investor Relations:

Employees

Shareholders

Mutual fund holders8.07%
Individual stakeholders58.05%
Other institutional17.97%

Top Executives

Ted WhitePresident, Chief Executive Officer & Director
Terence KohlerChief Financial Officer
Gary GoldenbergChief Medical Officer
Eugene ScavolaExecutive Vice President-Technical Operations
Christopher G. HayesSecretary, Chief Legal & Compliance Officer